Gutiérrez-Ortiz Eva, López-Guarch Carmen Jiménez, Jiménez Juan Francisco Delgado, Coronel María Lorena, Martín de Miguel Irene, Biscotti Rodil Belen, Duarte Torres Juan, Segura de la Cal Teresa, Velázquez Martín María Teresa, Arribas Ynsaurriaga Fernando, Cruz-Utrilla Alejandro, Escribano-Subías Pilar
Pulmonary Hypertension Unit, Department of Cardiology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Cardiology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
J Clin Med. 2025 Mar 14;14(6):1968. doi: 10.3390/jcm14061968.
: Ventricular-arterial (VA) coupling, assessed via the TAPSE/PASP ratio, is a well-established prognostic marker in pulmonary arterial hypertension (PAH). However, transthoracic echocardiography (TTE) often fails to estimate the pulmonary artery systolic pressure (PASP). This study evaluated the prognostic value of TAPSE/PASP when PSAP was obtained both via TEE and RHC and their correlation. : A prospective registry included 90 PAH patients (April 2021-May 2024). TTE and RHC were performed according to clinical guidelines. The correlation and agreement between both techniques were assessed using Spearman's rank correlation and a Bland-Altman analysis. The prognostic utility of TAPSE/PASP for clinical worsening (CW) (death or lung transplantation) was evaluated using Cox models, Harrell's c-statistics, and ROC curve analysis. : The median interval between TTE and RHC was 1.5 days (range -3 to +43). TAPSE/PASP showed a strong correlation between both techniques (rho = 0.74, < 0.001), though TTE slightly overestimated values due to PASP underestimation. The PASP correlation was moderate (rho = 0.56, < 0.001). CW occurred in 17.8% of patients. According to cut-off points established based on ESC/ERS guidelines, VA coupling via TTE effectively stratified the risk of CW (HR 7.0, = 0.076 and HR 34.8, = 0.002 for intermediate and high risk, respectively), whereas VA coupling with PASP measured via RHC showed no association with CW. TAPSE/PASP based on TTE demonstrated superior prognostic performance (C-index = 0.81) over RHC-derived parameters (C-index = 0.58). : The TAPSE/PASP ratio showed a strong correlation between TTE and RHC. However, while RHC remains the gold standard for hemodynamic assessments, echocardiographic measurements demonstrated superior performance in risk stratification, supporting its role as a valuable non-invasive tool in PAH.
通过TAPSE/PASP比值评估的心室-动脉(VA)耦联是肺动脉高压(PAH)中一种成熟的预后标志物。然而,经胸超声心动图(TTE)常常无法准确估计肺动脉收缩压(PASP)。本研究评估了通过经食管超声心动图(TEE)和右心导管检查(RHC)获得PSAP时TAPSE/PASP的预后价值及其相关性。:一项前瞻性登记研究纳入了90例PAH患者(2021年4月至2024年5月)。根据临床指南进行TTE和RHC检查。使用Spearman等级相关性分析和Bland-Altman分析评估两种技术之间的相关性和一致性。使用Cox模型、Harrell c统计量和ROC曲线分析评估TAPSE/PASP对临床恶化(CW)(死亡或肺移植)的预后效用。:TTE和RHC之间的中位间隔时间为1.5天(范围-3至+43天)。两种技术之间TAPSE/PASP显示出强相关性(rho = 0.74,P < 0.001),不过由于PASP被低估,TTE略微高估了数值。PASP相关性为中等(rho = 0.56,P < 0.001)。17.8%的患者发生了CW。根据基于ESC/ERS指南确定的截断点,通过TTE评估的VA耦联有效地对CW风险进行了分层(中危和高危的HR分别为7.0,P = 0.076和HR 34.8,P = 0.002),而通过RHC测量的PASP评估的VA耦联与CW无关联。基于TTE的TAPSE/PASP显示出优于RHC衍生参数(C指数 = 0.58)的预后性能(C指数 = 0.81)。:TAPSE/PASP比值在TTE和RHC之间显示出强相关性。然而,虽然RHC仍然是血流动力学评估的金标准,但超声心动图测量在风险分层方面表现出更优性能,支持其作为PAH中有价值的非侵入性工具的作用。